Aiming towards innovation, progress and scientific interaction, Biomedcode has invested over the years in forming productive collaborations both with academic institutes as well as with pharmaceutical and biotech companies.
With an experienced team of scientists both in its scientific board as well as in its board of directors, Biomedcode has extensive expertise in basic and translational research and in particular in immunology, cellular and molecular biology, pharmacology, histopathology and complementary fields.
This expertise has resulted over the years in many collaborations with academia and pharmaceutical companies.
- Collaborative Animal model development
The generation, characterization and use of transgenic mice for the preclinical efficacy evaluation of therapeutics constitute one of the main R&D activities of Biomedcode.
Biomedcode welcomes suggestions and proposals for the development of novel animal disease models as well as for the generation of animals humanized for targets of interest. Such development of novel models can be also performed in the context of a collaboration.
- Participation in EU and National funded research projects
The participation of SMEs in European and National funded projects offers a competitive advantage and added value to the project. Having a strong R&D department with great experience and expertise in drug development, animal model and assay development and preclinical efficacy evaluation, the contribution of Biomedcode has been greatly valued by our partners, as documented by our participation in several collaborative research projects.
Biomedcode is always open to discussing its participation in European and National networks and collaborative projects. Read more>
Contact us today to discuss our possible collaboration.